Citigroup
CORV

Citigroup’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Citigroup’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-10
Closed – – 7935
2015
Q4 		$0 Sell
10
-10
-50% -$83 ﹤0.01% 8019
2015
Q3 		$0 Buy
+20
New +$184 ﹤0.01% 7933
2015
Q2 		– Sell
-1,298
Closed -$12K – 7885
2015
Q1 		$12K Buy
+1,298
New +$12.4K ﹤0.01% 6392
2014
Q3 		– Sell
-185
Closed -$1K – 7413
2014
Q2 		$1K Buy
+185
New +$1.4K ﹤0.01% 7001
2014
Q1 		– Sell
-167
Closed -$1K – 7295
2013
Q4 		$1K Buy
+167
New +$876 ﹤0.01% 6899

Other funds holding CORV

Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PC
PointState Capital New York $4.31B AUM 42.31% 1-Year Est. Return
AIS
AlphaOne Investment Services West Chester, Pennsylvania $79.4M AUM 49.42% 1-Year Est. Return
TI
Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return